Biogen to purchase Reata Pharma
Pharma & Medical ProductsBiogen to Acquire Reata Pharmaceuticals in $7.3B DealBiogen to Acquire Reata Pharmaceuticals in $7.3B Deal
The rare-disease drug maker will add to Biogen's portfolio.
Sign up for the Powder & Bulk Solids Weekly newsletter.